The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease
Identifieur interne : 002580 ( Main/Exploration ); précédent : 002579; suivant : 002581The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease
Auteurs : David J. Gill [États-Unis] ; Arielle Freshman [États-Unis] ; Jennifer A. Blender [États-Unis] ; Bernard Ravina [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2008-05-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Cognition, Cognition Disorders (diagnosis), Cognition Disorders (epidemiology), Cognitive disorder, Female, Humans, Male, Mass Screening, Medical screening, Nervous system diseases, Neuropsychological Tests, Parkinson Disease (epidemiology), Parkinson disease, Parkinson's disease, Psychometrics, Severity of Illness Index, Space Perception (physiology), Visual Perception (physiology), cognition, screening.
- MESH :
- diagnosis : Cognition Disorders.
- epidemiology : Cognition Disorders, Parkinson Disease.
- physiology : Space Perception, Visual Perception.
- Aged, Female, Humans, Male, Mass Screening, Neuropsychological Tests, Psychometrics, Severity of Illness Index.
Abstract
Cognitive impairment is common in Parkinson's disease (PD) and can occur early in the disease course. No effective screening test exists for detection of early or mild cognitive impairment in PD. We examined the Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive dysfunction in PD. The test–retest intraclass correlation coefficient was 0.79 and the interrater intraclass correlation coefficient was 0.81. The correlation coefficient between the MoCA and a neuropsychologic battery was 0.72. The MoCA is reliable and valid in the PD population and warrants further study as a screening tool for cognitive dysfunction. © 2008 Movement Disorder Society
Url:
DOI: 10.1002/mds.22017
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003431
- to stream Istex, to step Curation: 003431
- to stream Istex, to step Checkpoint: 001136
- to stream PubMed, to step Corpus: 002280
- to stream PubMed, to step Curation: 002280
- to stream PubMed, to step Checkpoint: 002055
- to stream Ncbi, to step Merge: 002081
- to stream Ncbi, to step Curation: 002081
- to stream Ncbi, to step Checkpoint: 002081
- to stream Main, to step Merge: 003158
- to stream PascalFrancis, to step Corpus: 001242
- to stream PascalFrancis, to step Curation: 001A77
- to stream PascalFrancis, to step Checkpoint: 001056
- to stream Main, to step Merge: 003664
- to stream Main, to step Curation: 002580
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease</title><author><name sortKey="Gill, David J" sort="Gill, David J" uniqKey="Gill D" first="David J." last="Gill">David J. Gill</name></author><author><name sortKey="Freshman, Arielle" sort="Freshman, Arielle" uniqKey="Freshman A" first="Arielle" last="Freshman">Arielle Freshman</name></author><author><name sortKey="Blender, Jennifer A" sort="Blender, Jennifer A" uniqKey="Blender J" first="Jennifer A." last="Blender">Jennifer A. Blender</name></author><author><name sortKey="Ravina, Bernard" sort="Ravina, Bernard" uniqKey="Ravina B" first="Bernard" last="Ravina">Bernard Ravina</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:AD00C8F8891508DEE4091E1BF7C3D04792A56053</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.22017</idno><idno type="url">https://api.istex.fr/document/AD00C8F8891508DEE4091E1BF7C3D04792A56053/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003431</idno><idno type="wicri:Area/Istex/Curation">003431</idno><idno type="wicri:Area/Istex/Checkpoint">001136</idno><idno type="wicri:doubleKey">0885-3185:2008:Gill D:the:montreal:cognitive</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:18381646</idno><idno type="wicri:Area/PubMed/Corpus">002280</idno><idno type="wicri:Area/PubMed/Curation">002280</idno><idno type="wicri:Area/PubMed/Checkpoint">002055</idno><idno type="wicri:Area/Ncbi/Merge">002081</idno><idno type="wicri:Area/Ncbi/Curation">002081</idno><idno type="wicri:Area/Ncbi/Checkpoint">002081</idno><idno type="wicri:Area/Main/Merge">003158</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:08-0305138</idno><idno type="wicri:Area/PascalFrancis/Corpus">001242</idno><idno type="wicri:Area/PascalFrancis/Curation">001A77</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001056</idno><idno type="wicri:doubleKey">0885-3185:2008:Gill D:the:montreal:cognitive</idno><idno type="wicri:Area/Main/Merge">003664</idno><idno type="wicri:Area/Main/Curation">002580</idno><idno type="wicri:Area/Main/Exploration">002580</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease</title><author><name sortKey="Gill, David J" sort="Gill, David J" uniqKey="Gill D" first="David J." last="Gill">David J. Gill</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Neurology, University of Rochester, Rochester</wicri:cityArea></affiliation></author><author><name sortKey="Freshman, Arielle" sort="Freshman, Arielle" uniqKey="Freshman A" first="Arielle" last="Freshman">Arielle Freshman</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Neurology, University of Rochester, Rochester</wicri:cityArea></affiliation></author><author><name sortKey="Blender, Jennifer A" sort="Blender, Jennifer A" uniqKey="Blender J" first="Jennifer A." last="Blender">Jennifer A. Blender</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Clinical and Social Sciences in Psychology, University of Rochester, Rochester</wicri:cityArea></affiliation></author><author><name sortKey="Ravina, Bernard" sort="Ravina, Bernard" uniqKey="Ravina B" first="Bernard" last="Ravina">Bernard Ravina</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Neurology, University of Rochester, Rochester</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-05-15">2008-05-15</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="1043">1043</biblScope><biblScope unit="page" to="1046">1046</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">AD00C8F8891508DEE4091E1BF7C3D04792A56053</idno><idno type="DOI">10.1002/mds.22017</idno><idno type="ArticleID">MDS22017</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Cognition</term><term>Cognition Disorders (diagnosis)</term><term>Cognition Disorders (epidemiology)</term><term>Cognitive disorder</term><term>Female</term><term>Humans</term><term>Male</term><term>Mass Screening</term><term>Medical screening</term><term>Nervous system diseases</term><term>Neuropsychological Tests</term><term>Parkinson Disease (epidemiology)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Psychometrics</term><term>Severity of Illness Index</term><term>Space Perception (physiology)</term><term>Visual Perception (physiology)</term><term>cognition</term><term>screening</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cognition Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Space Perception</term><term>Visual Perception</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Mass Screening</term><term>Neuropsychological Tests</term><term>Psychometrics</term><term>Severity of Illness Index</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Cognition</term><term>Dépistage</term><term>Maladie de Parkinson</term><term>Pathologie du système nerveux</term><term>Trouble cognitif</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cognitive impairment is common in Parkinson's disease (PD) and can occur early in the disease course. No effective screening test exists for detection of early or mild cognitive impairment in PD. We examined the Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive dysfunction in PD. The test–retest intraclass correlation coefficient was 0.79 and the interrater intraclass correlation coefficient was 0.81. The correlation coefficient between the MoCA and a neuropsychologic battery was 0.72. The MoCA is reliable and valid in the PD population and warrants further study as a screening tool for cognitive dysfunction. © 2008 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Gill, David J" sort="Gill, David J" uniqKey="Gill D" first="David J." last="Gill">David J. Gill</name></region><name sortKey="Blender, Jennifer A" sort="Blender, Jennifer A" uniqKey="Blender J" first="Jennifer A." last="Blender">Jennifer A. Blender</name><name sortKey="Freshman, Arielle" sort="Freshman, Arielle" uniqKey="Freshman A" first="Arielle" last="Freshman">Arielle Freshman</name><name sortKey="Ravina, Bernard" sort="Ravina, Bernard" uniqKey="Ravina B" first="Bernard" last="Ravina">Bernard Ravina</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002580 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002580 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:AD00C8F8891508DEE4091E1BF7C3D04792A56053
|texte= The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |